Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.92M Sell
114,500
-5,400
-5% -$239K 1.79% 15
2021
Q2
$4.7M Hold
119,900
1.67% 18
2021
Q1
$4.34M Hold
119,900
1.86% 14
2020
Q4
$4.41M Sell
119,900
-19,123
-14% -$701K 2% 10
2020
Q3
$4.84M Hold
139,023
2.84% 9
2020
Q2
$4.31M Hold
139,023
2.35% 11
2020
Q1
$4.31M Hold
139,023
2.72% 9
2019
Q4
$5.17M Hold
139,023
2.09% 14
2019
Q3
$4.74M Sell
139,023
-13,807
-9% -$502K 1.99% 14
2019
Q2
$6.28M Hold
152,830
2.65% 13
2019
Q1
$6.16M Sell
152,830
-230,592
-60% -$9.23M 2.45% 13
2018
Q4
$15.9M Sell
383,422
-90,958
-19% -$3.78M 7.46% 2
2018
Q3
$19.8M Hold
474,380
6.44% 2
2018
Q2
$16.3M Sell
474,380
-147,560
-24% -$5.04M 6.12% 2
2018
Q1
$20.9M Sell
621,940
-361,733
-37% -$12.4M 8.63% 2
2017
Q4
$33.8M Sell
983,673
-47,852
-5% -$1.63M 13.44% 2
2017
Q3
$34.9M Sell
1,031,525
-60,078
-6% -$1.93M 14.93% 2
2017
Q2
$34.8M Buy
1,091,603
+65,348
+6% +$2.06M 14.52% 2
2017
Q1
$33.3M Hold
1,026,255
16.03% 2
2016
Q4
$31.6M Sell
1,026,255
-20,026
-2% -$611K 15.92% 2
2016
Q3
$33.6M Sell
1,046,281
-2,845
-0.3% -$95.1K 17.36% 2
2016
Q2
$35M Hold
1,049,126
8.07% 2
2016
Q1
$29.5M Hold
1,049,126
7.86% 2
2015
Q4
$32.1M Hold
1,049,126
8.81% 2
2015
Q3
$31.3M Sell
1,049,126
-1,054
-0.1% -$33.8K 9.02% 2
2015
Q2
$33.4M Hold
1,050,180
6.91% 2
2015
Q1
$34.7M Sell
1,050,180
-171,802
-14% -$5.46M 7.47% 2
2014
Q4
$36.1M Hold
1,221,982
8.51% 2
2014
Q3
$34.3M Hold
1,221,982
6.52% 2
2014
Q2
$34.4M Sell
1,221,982
-3,795
-0.3% -$108K 6.17% 2
2014
Q1
$37.4M Hold
1,225,777
7.14% 2
2013
Q4
$35.6M Sell
1,225,777
-142,817
-10% -$4.16M 7.27% 2
2013
Q3
$37.3M Hold
1,368,594
7.13% 2
2013
Q2
$36.4M Buy
+1,368,594
New +$37.8M 7.57% 2

Other funds holding PFE

David M. Knott's PFE Position: Q3 2021 in Review

David M. Knott reduced its Pfizer (PFE) stake by 4.5% in Q3 2021, selling an estimated $239K and leaving 114,500 shares worth $4.92M. The position accounts for 1.79% of the portfolio, ranked #15.

David M. Knott first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. The position peaked at $37.4M in Q1 2014. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • David M. Knott held 114,500 shares of Pfizer worth $4.92M as of Q3 2021.
  • David M. Knott sold 5,400 Pfizer shares in Q3 2021, an estimated $239K.
  • Pfizer made up 1.79% of David M. Knott's portfolio in Q3 2021, its #15 holding.
  • David M. Knott first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
  • David M. Knott's Pfizer position peaked at $37.4M in Q1 2014.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.